我国药品集中采购政策研究:综述与展望
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Research on Centralized Drug Procurement Policy in China:Review and Prospect
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    药价虚高是我国医疗卫生事业发展中急需解决的问题,近年来我国不断推进药品集中采购,全国各地涌现出多种多样的药品集中采购模式,在控制药价方面取得了显著成效,同时采购模式的转变对药品采购的供应链成员也造成了巨大影响。本文从我国药品集中采购的政策演进、模式研究以及模式效果的适应场景与效果评价三个角度出发对我国药品集中采购的相关研究进行了梳理,提出了相关文献的贡献及不足,并展望日后的研究方向,以期对我国药品集中采购的相关研究提供参考。

    Abstract:

    The artificially high price of drugs is an urgent problem that needs to be solved in the development of medical and health services in China.In recent years,with the continuous progress in the policy of the centralized procurement of drugs,various centralized drug procurement patterns have emerged throughout the country,achieving significant results in the control of drug prices,and the centralized procurement of drugs has a huge impact on the supply chain members of drug procurement.This study reviews the relevant researches on centralized procurement of drugs in China from three perspectivesinclding policy evolution of centralized procurement of drugs,model research and adaptive scenarios,as well as effects evaluation of the model.In order to provide a reference for the related research on centralized procurement of drugs in China,the contributions and deficiencies of relevant literatures have been put forward,and the future research direction has been prospected.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-12-02